Pfizer PFE
NYSE PFE
$30.03 -0.39 (-1.27%)
As of: Oct 23, 2026 · 2:56 PM EDT

Pfizer (PFE) Gains from Sales and Divestitures (2012 - 2020)

Updated

Pfizer's Gains from Sales and Divestitures was $1 million in FY2018, compared with -$55 million in FY2017.

Analysis

Pfizer (PFE) Gains from Sales and Divestitures (2012 - 2020) Analysis & Trends

From FY2009 onward, Pfizer has reported Gains from Sales and Divestitures for 6 years.

  • The FY2018 figure marks the highest annual Gains from Sales and Divestitures since FY2010.
  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was -$55 million in FY2017 and -$1.71 billion in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,127.89 Bn 1,096.47 Bn 19.71 Bn
2 Johnson & Johnson 635.11 Bn 554.97 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.80 Bn 12.70 Bn
4 Merck 358.24 Bn 312.62 Bn 12.21 Bn
5 Novartis Ag 290.13 Bn 254.12 Bn 11.24 Bn
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn
7 Amgen 237.87 Bn 193.27 Bn 7.24 Bn
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn
10 Vertex Pharmaceuticals 133.37 Bn 105.38 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 29, 2020 6.00 Mn
Dec 31, 2019 21.00 Mn
Sep 29, 2019 8.23 Bn
Sep 30, 2018 2.00 Mn
Jul 1, 2018 2.00 Mn
Apr 1, 2018 -3.00 Mn
Dec 31, 2017 52.00 Mn
Oct 1, 2017 12.00 Mn
Jul 2, 2017 -28.00 Mn
Apr 2, 2017 -37.00 Mn
Dec 31, 2016 -290.00 Mn
Oct 2, 2016 -1.42 Bn
Dec 31, 2014 -14.00 Mn
Jun 29, 2014 2.00 Mn
Dec 31, 2013 -55.00 Mn
Jun 30, 2013 10.54 Bn
Mar 31, 2013 490.00 Mn
Dec 31, 2012 7.12 Bn
API Access

Pfizer Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PFE&period=max&api_key=YOUR_API_KEY